Cognex (CGNX) Financials

Cognex (NASDAQ: CGNX) is showing a strong operating recovery in 2026. Revenue reached $291.3 million in Q2 2026, up 21.7% from $239.3 million in Q2 2024 and 16.9% from $249.1 million in the restated Q2 2025 results. The improvement follows a broader upward trend from roughly $197 million to $242.5 million in comparable Q2 periods between 2023 and 2026.

Profitability has improved even faster than sales. Q2 2026 gross profit was $205.8 million, producing a gross margin of approximately 70.7%, compared with 67.4% in Q2 2025 and 69.6% in Q2 2024. Operating income more than doubled year over year to $85.5 million, while net income increased to $72.8 million from $40.5 million. Earnings per diluted share rose to $0.43 from $0.24.

The first half of 2026 also shows positive momentum. Q1 and Q2 revenue totaled approximately $559.7 million, up about 22.5% from the comparable first half of 2025. Operating income increased approximately 168% to $145.0 million, and net income rose roughly 146% to $124.3 million. The data suggests improving demand and operating leverage, although investors should remember that several prior-period figures were restated.

Cognex is also generating substantial cash. Operating cash flow was $69.2 million in Q2 2026, up from $42.6 million in Q2 2025, and first-half operating cash flow reached $114.2 million. The company ended Q2 with $302.5 million in cash, $101.8 million in short-term investments and $350.6 million in long-term investments, providing considerable financial flexibility.

• Accelerating revenue growth: Q2 2026 revenue increased 16.9% year over year and 21.7% compared with Q2 2024, extending the recovery from the weaker 2023 period.
• Significant margin expansion: Q2 gross margin improved to approximately 70.7%, while operating margin rose to approximately 29.4% from 15.9% in Q2 2025.
• Strong earnings growth: Q2 net income increased approximately 80% year over year, and diluted EPS climbed from $0.24 to $0.43.
• Operating leverage: Q2 revenue grew substantially while total operating expenses declined to $120.3 million from $124.4 million in the restated year-earlier quarter.
• Improving cash generation: First-half operating cash flow increased to approximately $114.2 million from $82.9 million in the comparable 2025 period.
• Strong liquidity: Cash and short- and long-term investments totaled approximately $755 million at Q2-end, compared with roughly $513 million at the end of Q1 2025.
• Shareholder returns remain active: Cognex paid $14.3 million in dividends and repurchased $7.4 million of stock in Q2, but it also issued $88.4 million of common equity, making the overall capital-allocation picture unusual.
• Working capital remains a cash-flow variable: Changes in operating assets and liabilities reduced Q2 operating cash flow by $25.9 million, following an even larger $27.9 million drag in Q1.
• Investment outflows were substantial: Cognex purchased $85.9 million of investments in Q2, contributing to $70.5 million of net investing cash outflow. These purchases may support liquidity management but temporarily reduce cash available for other uses.
• Balance-sheet concentration and dilution risks: Goodwill, intangible assets and deferred tax assets represent a significant portion of total assets, while Q2 diluted shares outstanding were about 0.9% higher than in the comparable 2025 quarter. Investors should monitor asset quality and whether future equity issuance offsets buybacks.

Overall, the statements point to a materially stronger 2026: revenue is growing, gross margins are expanding, operating expenses are controlled and operating cash flow is improving. The main issues to monitor are working-capital volatility, the unusually large Q2 equity issuance, investment-related cash usage and the substantial noncurrent asset balances on the balance sheet.